Inhibiting cyprinid herpesvirus-3 replication with CRISPR/Cas9
详细信息 查看全文
- 作者：Yicheng Zhao ; Tiedong Wang ; Ze Yu ; Heming Wang ; Bo Liu ; Chunyan Wu…
- 关键词：CRISPR/Cas9 ; Cyprinid herpesvirus ; 3 ; DNA polymerase ; Koi herpesvirus ; Thymidine kinase
- 刊名：Biotechnology Letters
- 出版年：2016
- 出版时间：April 2016
- 年：2016
- 卷：38
- 期：4
- 页码：573-578
- 全文大小：700 KB
- 参考文献：Costes B, Fournier G, Michel B, Delforge C, Raj VS, Dewals B, Gillet L, Drion P, Body A, Schynts F, Lieffrig F, Vanderplasschen A (2008) Cloning of the koi herpesvirus genome as an infectious bacterial artificial chromosome demonstrates that disruption of the thymidine kinase locus induces partial attenuation in Cyprinus carpio koi. J Virol 82:4955–4964CrossRef PubMed PubMedCentral
Dai Z, Wu R, Zhao Y, Wang K, Huang Y, Yang X, Xie Z, Tu C, Ouyang H, Wang T, Pang D (2014) Early lethality of shRNA-transgenic pigs due to saturation of microRNA pathways. J Zhejiang Univ Sci B 15:466–473CrossRef PubMed PubMedCentral
Davison AJ, Kurobe T, Gatherer D, Cunningham C, Korf I, Fukuda H, Hedrick RP, Waltzek TB (2013) Comparative genomics of carp herpesviruses. J Virol 87:2908–2922CrossRef PubMed PubMedCentral
Dong C, Weng S, Li W, Li X, Yi Y, Liang Q, He J (2011) Characterization of a new cell line from caudal fin of koi, Cyprinus carpio koi, and first isolation of cyprinid herpesvirus 3 in China. Virus Res 161:140–149CrossRef PubMed
Doudna JA, Charpentier E (2014) The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096CrossRef PubMed
Ebina H, Misawa N, Kanemura Y, Koyanagi Y (2013) Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 3:2510CrossRef PubMed PubMedCentral
Eide KE, Miller-Morgan T, Heidel JR, Kent ML, Bildfell RJ, LaPatra S, Watson G, Jin L (2011) Investigation of koi herpesvirus latency in koi. J Virol 85:4954–4962CrossRef PubMed PubMedCentral
Fuchs W, Fichtner D, Bergmann SM, Mettenleiter TC (2011) Generation and characterization of koi herpesvirus recombinants lacking viral enzymes of nucleotide metabolism. Arch Virol 156:1059–1063CrossRef PubMed
Gaj T, Gersbach CA, Barbas CF (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31:397–405CrossRef PubMed PubMedCentral
Gilad O, Yun S, Adkison MA, Way K, Willits NH, Bercovier H, Hedrick RP (2003) Molecular comparison of isolates of an emerging fish pathogen, koi herpesvirus, and the effect of water temperature on mortality of experimentally infected koi. J Gen Virol 84:2661–2667CrossRef PubMed
Gotesman M, Soliman H, Besch R, El-Matbouli M (2014) In vitro inhibition of cyprinid herpesvirus-3 replication by RNAi. J Virol Methods 206:63–66CrossRef PubMed PubMedCentral
Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31:827–832CrossRef PubMed PubMedCentral
Manjunath N, Yi G, Dang Y, Shankar P (2013) Newer gene editing technologies toward HIV gene therapy. Viruses 5:2748–2766CrossRef PubMed PubMedCentral
Rakus K, Ouyang P, Boutier M, Ronsmans M, Reschner A, Vancsok C, Jazowiecka-Rakus J, Vanderplasschen A (2013) Cyprinid herpesvirus 3: an interesting virus for applied and fundamental research. Vet Res 44:85CrossRef PubMed PubMedCentral
Ramanan V, Shlomai A, Cox DBT, Schwartz RE, Michailidis E, Bhatta A, Scott DA, Zhang F, Rice CM, Bhatia SN (2015) CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus. Sci Rep 5:10833CrossRef PubMed PubMedCentral
Schiffer JT, Swan DA, Stone D, Jerome KR (2013) Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach. PLoS Comput Biol 9:e1003131CrossRef PubMed PubMedCentral
Zhao Y, Pang D, Wang T, Yang X, Wu R, Ren L, Yuan T, Huang Y, Ouyang H (2011) Human MxA protein inhibits the replication of classical swine fever virus. Virus Res 156:151–155CrossRef PubMed
Zhao Y, Dai Z, Liang Y, Yin M, Ma K, He M, Ouyang H, Teng C (2014) Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system. Sci Rep 4:3943PubMed PubMedCentral - 作者单位：Yicheng Zhao (1) (2)
Tiedong Wang (2)
Ze Yu (1)
Heming Wang (1)
Bo Liu (2) (3)
Chunyan Wu (1)
Chun-Bo Teng (1)
1. College of Life Sciences, Northeast Forestry University, Harbin, China
2. College of Animal Sciences, Jilin University, Changchun, China
3. College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot, China - 刊物类别：Biomedical and Life Sciences
- 刊物主题：Life Sciences
Microbiology
Biotechnology
Applied Microbiology
Biochemistry - 出版者：Springer Netherlands
- ISSN：1573-6776
文摘
Objectives The potential of CRISPR/Cas9 gene editing to repress CyHV-3 was tested in vitro.